T1	Participants 605 738	children aged 6-18 years newly diagnosed with cancer in eastern Denmark (n=120) and a matched control group in western Denmark (n=120
T2	Participants 749 855	includes Danish-speaking children diagnosed with cancer and treated at pediatric oncology units in Denmark
T3	Participants 1868 1982	patients are tested at diagnosis, at 3 and 6 months after diagnosis, and one year after the cessation of treatment
